Trials / Conditions / Low Bone Mineral Density

Low Bone Mineral Density

12 registered clinical trials studyying Low Bone Mineral Density — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Impact of Core Stability Versus Respiratory Muscle Strengthening Exercises on Bone Mineral Density in Chil NCT07328165	Cairo University	N/A
Recruiting	Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis NCT05902078	Shanghai Jiao Tong University Affiliated Sixth People's Hospital	Phase 4
Completed	Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosu NCT00925600	Amgen	Phase 3
Completed	Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis NCT00980174	Amgen	Phase 3
Completed	A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated NCT00890981	Amgen	Phase 3
Completed	Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density NCT00896532	Amgen	Phase 2
Completed	A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Ost NCT00887965	Amgen	Phase 2
Completed	A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-fille NCT00515463	Amgen	Phase 3
Completed	An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Post NCT00325468	Amgen	Phase 3
Completed	AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Br NCT00089661	Amgen	Phase 3
Completed	Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Wome NCT00043186	Amgen	Phase 2
Completed	Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease NCT01215890	University of Alberta	Phase 4